Growth Metrics

Ironwood Pharmaceuticals (IRWD) Accumulated Depreciation & Amortization (2016 - 2024)

Historic Accumulated Depreciation & Amortization for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Q4 2024 value amounting to $1.2 million.

  • Ironwood Pharmaceuticals' Accumulated Depreciation & Amortization changed 0.0% to $1.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.2 million for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q4 2024, Ironwood Pharmaceuticals' Accumulated Depreciation & Amortization is $1.2 million, which was down 0.0% from $1.2 million recorded in Q4 2023.
  • In the past 5 years, Ironwood Pharmaceuticals' Accumulated Depreciation & Amortization ranged from a high of $2.3 million in Q4 2020 and a low of $1.2 million during Q4 2023
  • Over the past 5 years, Ironwood Pharmaceuticals' median Accumulated Depreciation & Amortization value was $1.4 million (recorded in 2022), while the average stood at $1.5 million.
  • In the last 5 years, Ironwood Pharmaceuticals' Accumulated Depreciation & Amortization plummeted by 5892.86% in 2020 and then changed by 0.0% in 2024.
  • Ironwood Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $2.3 million in 2020, then crashed by 34.78% to $1.5 million in 2021, then fell by 6.67% to $1.4 million in 2022, then fell by 14.29% to $1.2 million in 2023, then changed by 0.0% to $1.2 million in 2024.
  • Its Accumulated Depreciation & Amortization stands at $1.2 million for Q4 2024, versus $1.2 million for Q4 2023 and $1.4 million for Q4 2022.